Company Quick10K Filing
Endonovo Therapeutics
10-Q 2020-09-30 Filed 2020-11-19
10-Q 2020-06-30 Filed 2020-08-19
S-1 2020-06-23 Public Filing
10-Q 2020-03-31 Filed 2020-06-12
10-K 2019-12-31 Filed 2020-05-04
10-Q 2019-09-30 Filed 2019-11-19
10-Q 2019-06-30 Filed 2019-08-13
10-Q 2019-03-31 Filed 2019-05-09
S-1 2019-01-07 Public Filing
10-K 2018-12-31 Filed 2019-04-15
10-Q 2018-09-30 Filed 2018-11-13
10-Q 2018-06-30 Filed 2018-08-13
10-Q 2018-03-31 Filed 2018-05-18
10-K 2017-12-31 Filed 2018-04-06
10-Q 2017-09-30 Filed 2017-11-07
10-Q 2017-06-30 Filed 2017-08-10
10-Q 2017-03-31 Filed 2017-05-12
10-K 2016-12-31 Filed 2017-04-17
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-12
10-Q 2016-03-31 Filed 2016-05-20
10-K 2015-12-31 Filed 2016-04-05
10-Q 2015-09-30 Filed 2015-11-23
10-Q 2015-06-30 Filed 2015-08-19
10-Q 2015-03-31 Filed 2015-05-19
10-K 2014-12-31 Filed 2015-04-03
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-19
10-Q 2014-03-31 Filed 2014-05-15
10-K 2013-12-31 Filed 2014-04-15
10-Q 2013-09-30 Filed 2013-12-18
10-Q 2013-06-30 Filed 2013-08-19
10-Q 2013-03-31 Filed 2013-05-20
10-K 2012-12-31 Filed 2013-04-16
10-K 2012-12-31 Filed 2013-04-16
10-Q 2012-09-30 Filed 2012-11-29
10-Q 2012-06-30 Filed 2012-08-20
10-Q 2012-03-31 Filed 2012-05-21
10-K 2011-12-31 Filed 2012-04-13
8-K 2020-08-06
8-K 2020-05-20
8-K 2020-05-19
8-K 2020-04-10
8-K 2020-03-02
8-K 2020-01-29
8-K 2019-12-11
8-K 2019-06-10
8-K 2019-01-01
8-K 2018-12-06
8-K 2018-09-18
8-K 2018-08-12

Endonovo Therapeutics Financials

ENDV Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546,418 322,654 0 0 0 0 -853,740
1 800 Flowers Com (FLWS) 944,324 42% 13.3 6% 664,955 335,559 1,266,390 533,727 36,761 75,090 1,000,932
10x Genomics (TXG) 4,804,979 75% -490.3 -2% 572,815 151,367 61,207 45,727 -9,603 -8,887 4,357,180
12 Retech (RETC) 0 32% -0.1 -1,385% 1,118 20,421 625 199 -15,491 -14,800 966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 33,711 0% 0.4 -5% 164,088 108,405 18,194 0 -7,969 -8,017 -2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 18,527 23,194 27,219 6,699 -2,862 -1,433 3,396
1895 Bancorp of Wisconsin (BCOW) 46,152,715 12,508.1 -0% 441,187 382,722 0 0 -44 3,689 46,142,359
1st Constitution Bancorp (FCCY) 164,504 0% 4.4 1% 1,342,565 1,204,038 490 0 13,787 32,503 143,748
1st Franklin Financial (FFC) 3,551 -0.6 7% 905,107 644,730 0 0 62,078 80,004 -45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200,033 7.9 1% 6,691,070 5,858,028 0 0 70,061 136,342 1,072,548
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 1,849 0 0 -1,663 -1,654 250
21Vianet Group (VNET) 6,005,116 0% 11,150,717 5,787,533 0 0 0 0 3,344,095
22nd Century (XXII) 301,854 1% -14.1 -36% 61,864 6,554 25,706 304 -22,433 -21,464 301,826
1Life Healthcare (ONEM)

Balance Sheet ($'000)2011-06-302011-12-312012-03-312012-06-302012-09-302013-09-302015-06-302015-09-302015-12-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash111705211311827417995561132464909568665379585485
Accounts Receivable11127103310811
Inventory
PP&E55221517474787878787878787887878787878990
Assets114731,027988969645462761022643193582031604,6124,4714,2844,7114,2423,7664,1233,414
Accounts Payable01157199281346
Long-Term Debt433532292,2851,8783,1942,8003,2953,6407,3567,3017,4898,4138,1587,4807,5207,453
Liabilities011,7462,1042,3953,5275,4515,9917,6657,3538,7838,88113,4259,35713,34414,16313,09413,40018,79315,63415,39120,36919,980
Stockholders' Equity11472-719-1,116-1,426-3,463-5,398-5,929-7,589-7,250-8,519-8,562-13,066-9,154-13,184-9,550-8,623-9,116-14,082-11,392-11,625-16,247-16,566
Income Statement ($'000)2011-06-302011-12-312012-03-312012-06-302012-09-302013-09-302015-06-302015-09-302015-12-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue928702-000007132142456354
Cost of Revenue1000001488309
Gross Profit1-00000121734373345
R&D114445111634835
SG&A
Tax0000000000000000000000
Net Income21-431-431-393-452-558-1,281-2,840-1,454-2,219-740-7,7651,858-6,6721,769-6194,802-5,9481,382-2,406-7,838-1,406
Cash Flow ($'000)2011-06-302011-12-312012-03-312012-06-302012-09-302013-09-302015-06-302015-09-302015-12-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-20-176-33-429-211-776-659-434-914-829-813-591-742-830-716-528-688-1,017
Cash Investing530000000-3,000-90000-2-1
Cash Financing10135254382297926204928258823,8266057141,4284302081,179475